1. Home
  2. ULY vs OGEN Comparison

ULY vs OGEN Comparison

Compare ULY & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • OGEN
  • Stock Information
  • Founded
  • ULY 2013
  • OGEN 1996
  • Country
  • ULY United States
  • OGEN United States
  • Employees
  • ULY N/A
  • OGEN N/A
  • Industry
  • ULY
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULY
  • OGEN Health Care
  • Exchange
  • ULY Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • ULY 5.8M
  • OGEN 5.4M
  • IPO Year
  • ULY N/A
  • OGEN N/A
  • Fundamental
  • Price
  • ULY $2.69
  • OGEN $1.29
  • Analyst Decision
  • ULY Strong Buy
  • OGEN
  • Analyst Count
  • ULY 2
  • OGEN 0
  • Target Price
  • ULY $11.50
  • OGEN N/A
  • AVG Volume (30 Days)
  • ULY 994.9K
  • OGEN 206.2K
  • Earning Date
  • ULY 11-12-2025
  • OGEN 11-11-2025
  • Dividend Yield
  • ULY N/A
  • OGEN N/A
  • EPS Growth
  • ULY N/A
  • OGEN N/A
  • EPS
  • ULY N/A
  • OGEN N/A
  • Revenue
  • ULY $131,235,000.00
  • OGEN N/A
  • Revenue This Year
  • ULY N/A
  • OGEN N/A
  • Revenue Next Year
  • ULY $20.23
  • OGEN N/A
  • P/E Ratio
  • ULY N/A
  • OGEN N/A
  • Revenue Growth
  • ULY N/A
  • OGEN N/A
  • 52 Week Low
  • ULY $2.63
  • OGEN $1.01
  • 52 Week High
  • ULY $17.99
  • OGEN $18.90
  • Technical
  • Relative Strength Index (RSI)
  • ULY 34.89
  • OGEN 48.27
  • Support Level
  • ULY $2.63
  • OGEN $1.26
  • Resistance Level
  • ULY $3.07
  • OGEN $1.34
  • Average True Range (ATR)
  • ULY 0.26
  • OGEN 0.07
  • MACD
  • ULY 0.01
  • OGEN -0.01
  • Stochastic Oscillator
  • ULY 7.32
  • OGEN 20.00

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: